It looks like they have a cornerstone investor coming to help advance the pipeline. So, more dilution late in the year perhaps and maybe more preclinical work with that. The gene therapies and other attempts at HIV cures are still struggling for funds and there isn't a cure or vaccine imminent. Reservoirs being a major issue. Calimmune will be reporting on their four year old gene therapy trial soon...... the results are expected to be promising but no holy grail yet. Still room for HIV drugs that help the immune system. Probably worth averaging right down here, if you are a believer.
- Forums
- ASX - By Stock
- BIT
- Ann: Advisor appointed to advance commercialisation in China
Ann: Advisor appointed to advance commercialisation in China, page-7
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $24.36M |
Open | High | Low | Value | Volume |
2.6¢ | 2.7¢ | 2.6¢ | $438 | 16.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 121151 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 157830 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 121151 | 0.026 |
6 | 399400 | 0.025 |
3 | 3474583 | 0.024 |
1 | 130000 | 0.023 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 157830 | 2 |
0.028 | 145600 | 2 |
0.029 | 260000 | 2 |
0.030 | 49844 | 3 |
0.031 | 280868 | 5 |
Last trade - 12.25pm 15/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online